PQ Bypass

Pq Bypass

PQ Bypass Announces $60M Financing

8th January 2019

PQ Bypass Announces $60 Million Financing to Advance New Therapeutic Approach to Peripheral Arterial Disease. Funds Will Support Pivotal Trial of Novel DETOUR System Designed for Patients with Tough to Treat Long Blockages in Leg Arteries. January 08, 2019. Ireland […]

Read More
Pq Bypass

PQ Bypass Reports Positive 12-Month Results

28th June 2018

28 June 2018.  Results from the DETOUR I Trial evaluating the PQ Bypass DETOUR System for percutaneous bypass showed promising 12-month durability for patients with extremely long blockages in the superficial femoral artery (SFA).  The data were presented as a […]

Read More
Pq Bypass

Doctors Perform ‘Bypass’ Without Surgery

2nd March 2018

Seroba’s investee company, PQ Bypass was making eye-catching headlines in the USA this week.  Arkansas Heart Hospital is the first U.S. hospital to perform the DETOUR procedure and the story was carried on Little Rock’s news source, ArkansasMatters. You can […]

Read More
Pq Bypass

PQ Bypass Announces First Patient Treated in DETOUR II Trial

23rd February 2018

PQ Bypass Announces First Patient Treated in Landmark DETOUR II Trial Evaluating New Treatment Approach for Clogged Leg Arteries.  Pivotal Trial Now Underway in the United States for First-of-its-Kind Procedure in Patients with Severe Peripheral Artery Disease (PAD) SUNNYVALE, Calif. […]

Read More
Pq Bypass

PQ Bypass Unveils New Data From DETOUR I at VIVA 17

12th September 2017

Seroba’s investee company, PQ Bypass, today announced data from a subset analysis of the DETOUR I clinical trial during a late-breaking clinical trial session at Vascular InterVentional Advances (VIVA 17), which is taking place September 11-14 in Las Vegas. The […]

Read More
Frost Sullivan

PQ Bypass Wins 2017 Innovation Award

31st August 2017

LONDON, U.K. August 31, 2017. Frost & Sullivan has announced PQ Bypass as winner of the 2017 European PAD Interventions Technology Innovation Award. Each year, Frost & Sullivan presents this award to a company that has developed a pioneering technology that […]

Read More
Pq Bypass News 2

PQ Bypass Announces CE Mark for DETOUR Percutaneous Bypass

13th March 2017

Seroba’s investee company, PQ Bypass, today announced CE (Conformité Européenne) Mark approval for a trio of proprietary devices: TORUS™ Stent Graft System, PQ Snare, and PQ Crossing Device, which enables physicians to perform a fully percutaneous femoral-popliteal bypass in patients […]

Read More
T: 353 (0)1 633 4028

18 Herbert Street
Dublin 2
D02 FK19

Scroll to Top